ACR & Coalition Letters to Federal Policymakers

Rheumatology advocacy involves several branches of government and various agencies. ACR advocates to Congress, federal agencies, and others by writing or signing on to various policy letters.

2020 Federal Advocacy Letters

ACR Joins AMA Letter Asking Congress to Address Surprise Billing Separately from COVID-19 Recovery Legislation - 7/29/2020

ACR Joins Coalition Letter Asking Congress to Include the Resident Physician Shortage Reduction Act (HR 1763/S 348) in Next COVID-19 Package - 7/9/2020

ACR Joins Coalition Letter Urging CMS to Follow Through with E/M Increases, Documentation Improvements - 6/30/2020

ACR Writes to Thank House and Senate Leaders for Introducing the Workforce Resilience Act (HR 6788/S 3599) - 6/15/2020

ACR Joins AMA to Ask House and Senate Leaders for Liability Protections for Healthcare Providers in Next COVID-19 Legislative Package - 6/9/2020

ACR Signs Coalition letter to CMS Asking for Guardrails on the Use of Step Therapy - 5/29/2020

Coalition Open Letter to All Health Plans Calling for Suspension of Prior Authorization - 5/18/2020

ACR Signs Coalition letter Requesting Funding for Pediatric Subspecialty Loan Repayment Program in COVID Relief Legislation - 5/13/2020

ACR Comments on CMS Interim Final Rule on Policies Related to COVID-19 Public Health Emergency - 4/27/2020

ACR Signs Coalition Letter to Congress to Restrict Step Therapy Use During COVID-19 - 4/20/2020

ACR Signs Coalition Letter Requesting Inclusion of Support for Physician Practices in any Economic Stimulus Package - 3/25/2020

Joint Statement on Hydroxychloroquine Access During COVID-19 Crisis - 3/23/2020

32 Veterans Service Organizations Join ACR to Urge Congress to Dedicate DoD Funding to Researching Arthritis in the Military - 3/12/2020

ACR Signs Coalition Letter Requesting Labor-HHS Report Language on Researching Musculoskeletal Disease in Intersectional Populations - 3/11/2020

ACR Comments to Congress Supporting HR-5741 - Strengthening Innovation in Medicare and Medicaid Act - 3/11/2020

More Than 140 Patient, Provider, Retiree Organizations Urge Congress to Erect Safeguards Around Medicare, Medicaid Demonstration Projects - 3/10/2020

ACR Signs Coalition Letter to Congress to Support Safe Step Act - 3/6/2020

ACR Comments on 2021 HHS Notice of Benefit and Payment Parameters - 3/2/2020

ACR Signs Coalition Letter to CMS Supporting E/M Valuation and Complexity Code Policies - 2/10/2020

2019 Federal Advocacy Letters

2018 Federal Advocacy Letters

ACR Comments on 2019 Medicare Physician Fee Schedule Final Rule - 12/31/18

ACR Comments on Medicare Part B Drugs International Pricing Index Model - 12/27/18

Coalition Letter on Medicare Advantage Step Therapy - 10/1/18

ACR Response to CMS on Competitive Acquisition Program Request for Information - 9/24/18

ACR Letter to CMS on 2019 Physician Fee Schedule and Quality Payment Program - 9/6/18

ACR Comments in FDA Public Meeting on Biosimilars - 9/5/18

Stakeholder Letter to CMS on E/M Proposals in 2019 Medicare Physician Fee Schedule - 8/28/18

ACR Letter to HHS on Blueprint to Lower Drug Prices and Reduce Out of Pocket Costs - 7/13/18

Coalition Letter to CMS on Shortening the 2018 MIPS Reporting Period - 4/27/18

ACR Letter to CMS on Short-Term Limited Duration Insurance - 4/23/18

Coalition Letter to CMS on Short-Term Limited Duration Insurance - 4/23/18

Coalition Letter to CMS on Prior Authorization under Medicare Advantage and the Patients Over Paperwork Initiative - 4/4/18

Physician Group Letter to HHS on Drug Pricing Proposals - 3/14/18

ACR Comments to CMS on Clinical Laboratory Improvement Amendments - 3/12/18

ACR Comments to Department of Labor on Association Health Plan Proposed Rule - 3/5/18

ACR Response to HHS Request for Information on Promoting Healthcare Choice and Competition - 1/25/18

ACR Letter to FDA: Clarification of Orphan Designation of Drugs and Biologics for Pediatric Subpopulations of Common Diseases - 1/19/18

Coalition Letter to House on MIPS Adjustment to Part B Drugs - 1/18/18

Coalition Letter to Senate on MIPS Adjustment to Part B Drugs - 1/18/18

ACR Letter to CMS on Medicare Advantage Proposed Rule - 1/16/18

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us